Single Injection Of Ocriplasmin May Help Resolve Vitreomacular Adhesions

Thursday, May 10, 2012

Ocular Surgery News

Ocriplasmin, which is not approved by the U.S. Food and Drug Administration for use in cases of vitreomacular adhesions, may be useful for this indication, according to a speaker reporting phase 3 results of the MIVI-TRUST trial.

Full Story

Management of corneal edema secondary to endothelial dysfunction can include the below EXCEPT:
1. Hypertonic saline drops
2. Endothelial transplantation (DSEK/DSAEK)
3. Full thickness penetrating keratoplasty (PKP)
4. Anterior lamellar transplantation (ALK)
Check The Answer

Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Single Injection Of Ocriplasmin May Help Resolve Vitreomacular Adhesions

Comments

Quick Quiz

Management of corneal edema secondary to endothelial dysfunction can include the below EXCEPT:

AdGlare RMR Ad

Featured Products

Smartphone-Based Retinal Screening System

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2